BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 38671464)

  • 21. Genotoxicity, nitric oxide level modulation and cardio-protective potential of Kalanchoe Integra Var. Crenata (Andr.) Cuf Leaves in murine models.
    Asiedu-Gyekye IJ; Arhin E; Arthur SA; N'guessan BB; Amponsah SK
    J Ethnopharmacol; 2022 Jan; 283():114640. PubMed ID: 34606947
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Exercise preconditioning protects against doxorubicin-induced cardiac dysfunction.
    Hydock DS; Lien CY; Schneider CM; Hayward R
    Med Sci Sports Exerc; 2008 May; 40(5):808-17. PubMed ID: 18408619
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sex-dependent alteration of cardiac cytochrome P450 gene expression by doxorubicin in C57Bl/6 mice.
    Grant MK; Seelig DM; Sharkey LC; Zordoky BN
    Biol Sex Differ; 2017; 8():1. PubMed ID: 28078076
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Rehabilitative exercise in a rat model of doxorubicin cardiotoxicity.
    Hydock DS; Lien CY; Jensen BT; Parry TL; Schneider CM; Hayward R
    Exp Biol Med (Maywood); 2012 Dec; 237(12):1483-92. PubMed ID: 23354407
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Resistance training improves cardiac function and cardiovascular autonomic control in doxorubicin-induced cardiotoxicity.
    Feitosa LAS; Carvalho JDS; Dantas CO; de Souza DS; de Vasconcelos CML; Miguel-Dos-Santos R; Lauton-Santos S; Quíntans-Júnior LJ; Santos MRV; de Santana-Filho VJ; Barreto AS
    Cardiovasc Toxicol; 2021 May; 21(5):365-374. PubMed ID: 33387253
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Creatine and Resistance Training: A Combined Approach to Attenuate Doxorubicin-Induced Cardiotoxicity.
    Law D; Magrini MA; Siedlik JA; Eckerson J; Drescher KM; Bredahl EC
    Nutrients; 2023 Sep; 15(18):. PubMed ID: 37764831
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cardiometabolic Response to a Single High-intensity Interval Exercise Session Versus Breaking up Sedentary Time with Fragmented High-intensity Interval Exercise.
    Bailey DP; Orton CJ; Maylor BD; Zakrzewski-Fruer JK
    Int J Sports Med; 2019 Mar; 40(3):165-170. PubMed ID: 30716781
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Exercise training in doxorubicin-induced heart failure: effects on the L-arginine-NO pathway and vascular reactivity.
    Matsuura C; Brunini TM; Carvalho LC; Resende AC; Carvalho JJ; de Castro JP; Mendes-Ribeiro AC
    J Am Soc Hypertens; 2010; 4(1):7-13. PubMed ID: 20374946
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Cardioprotective Role of N-Acetyl Cysteine Amide in the Prevention of Doxorubicin and Trastuzumab-Mediated Cardiac Dysfunction.
    Goyal V; Bews H; Cheung D; Premecz S; Mandal S; Shaikh B; Best R; Bhindi R; Chaudhary R; Ravandi A; Thliveris J; Singal PK; Niraula S; Jassal DS
    Can J Cardiol; 2016 Dec; 32(12):1513-1519. PubMed ID: 27650929
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cardioprotective effects of exercise training on doxorubicin-induced cardiomyopathy: a systematic review with meta-analysis of preclinical studies.
    Ghignatti PVDC; Nogueira LJ; Lehnen AM; Leguisamo NM
    Sci Rep; 2021 Mar; 11(1):6330. PubMed ID: 33737561
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sustained Effects of High-Intensity Interval Exercise and Moderate-Intensity Continuous Exercise on Inhibitory Control.
    Tian S; Mou H; Qiu F
    Int J Environ Res Public Health; 2021 Mar; 18(5):. PubMed ID: 33800004
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Targeted disruption of p53 attenuates doxorubicin-induced cardiac toxicity in mice.
    Shizukuda Y; Matoba S; Mian OY; Nguyen T; Hwang PM
    Mol Cell Biochem; 2005 May; 273(1-2):25-32. PubMed ID: 16013437
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Advantages of prophylactic versus conventionally scheduled heart failure therapy in an experimental model of doxorubicin-induced cardiomyopathy.
    Lódi M; Priksz D; Fülöp GÁ; Bódi B; Gyöngyösi A; Nagy L; Kovács Á; Kertész AB; Kocsis J; Édes I; Csanádi Z; Czuriga I; Kisvárday Z; Juhász B; Lekli I; Bai P; Tóth A; Papp Z; Czuriga D
    J Transl Med; 2019 Jul; 17(1):229. PubMed ID: 31324258
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cardiotoxic Effects of the Antineoplastic Doxorubicin in a Model of Metabolic Syndrome: Oxidative Stress and Transporter Expression in the Heart.
    Ogonowski N; Rukavina Mikusic NL; Kouyoumdzian NM; Choi MR; Fellet A; Balaszczuk AM; Celuch SM
    J Cardiovasc Pharmacol; 2021 Dec; 78(6):784-791. PubMed ID: 34524257
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Scutellarin protects against doxorubicin-induced acute cardiotoxicity and regulates its accumulation in the heart.
    Sun XP; Wan LL; Yang QJ; Huo Y; Han YL; Guo C
    Arch Pharm Res; 2017 Jul; 40(7):875-883. PubMed ID: 28315259
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Exercise Protects Skeletal Muscle during Chronic Doxorubicin Administration.
    Dickinson JM; D'Lugos AC; Mahmood TN; Ormsby JC; Salvo L; Dedmon WL; Patel SH; Katsma MS; Mookadam F; Gonzales RJ; Hale TM; Carroll CC; Angadi SS
    Med Sci Sports Exerc; 2017 Dec; 49(12):2394-2403. PubMed ID: 28767526
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Cardioprotective Role of Flaxseed in the Prevention of Doxorubicin- and Trastuzumab-Mediated Cardiotoxicity in C57BL/6 Mice.
    Asselin CY; Lam A; Cheung DYC; Eekhoudt CR; Zhu A; Mittal I; Mayba A; Solati Z; Edel A; Austria JA; Aukema HM; Ravandi A; Thliveris J; Singal PK; Pierce GN; Niraula S; Jassal DS
    J Nutr; 2020 Sep; 150(9):2353-2363. PubMed ID: 32510147
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sex-related differences in delayed doxorubicin-induced cardiac dysfunction in C57BL/6 mice.
    Abdelgawad IY; George B; Grant MKO; Huang Y; Shan Y; Huang RS; Zordoky BN
    Arch Toxicol; 2024 Apr; 98(4):1191-1208. PubMed ID: 38244039
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Low-intensity exercise training during doxorubicin treatment protects against cardiotoxicity.
    Chicco AJ; Hydock DS; Schneider CM; Hayward R
    J Appl Physiol (1985); 2006 Feb; 100(2):519-27. PubMed ID: 16210442
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Switching to a low-fat diet attenuates the intensified doxorubicin cardiotoxicity associated with high-fat feeding.
    Hydock DS; Lien CY; Jensen BT; Schneider CM; Hayward R
    Cancer Chemother Pharmacol; 2013 Jun; 71(6):1551-60. PubMed ID: 23568281
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.